Condition: Advanced Lung Cancer · Sponsor: BioNTech SE
This study aims to investigate the combination of BNT324, a B7-H3 antibody-drug conjugate (ADC) with BNT327, a programmed death-ligand 1 (PD-L1) and vascular endothelial growth factor (VEGF) bispecific antibody, in participants with advanced/metastatic or relapsed/progressive small cell lung cancer (SCLC) and non small cell lung cancer (NSCLC).
This description comes directly from the study's public registry record.
BioNTech clinical trials patient information · +49 6131 9084 · patients@biontech.de
Always discuss trial participation with your own doctor first.
| Mayo Clinic Arizona | Phoenix, Arizona, United States | Recruiting |
| Precision NextGen Oncology and Research Center | Beverly Hills, California, United States | Recruiting |
| Cedars Sinai Medical Center | Los Angeles, California, United States | Recruiting |
| UCLA - David Geffen School of Medicine | Santa Monica, California, United States | Recruiting |
| University of Colorado Cancer Center | Aurora, Colorado, United States | Recruiting |
| Mayo Clinic in Florida | Jacksonville, Florida, United States | Recruiting |
| University of Iowa Hospitals & Clinics PARENT | Iowa City, Iowa, United States | Recruiting |
| Mayo Clinic-Rochester | Rochester, Minnesota, United States | Recruiting |
| John Theurer Cancer Center at Hackensack UMC | Hackensack, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Cancer Center (MSKCC) | New York, New York, United States | Recruiting |
| Icahn School of Medicine at Mount Sinai PRIME | New York, New York, United States | Recruiting |
| Cleveland Clinic Taussig Cancer Institute Case Comprehensive Cancer Center | Cleveland, Ohio, United States | Recruiting |
+ 76 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06892548